Title

Deprescribing in Older Adults With Cardiovascular Disease

UMMS Affiliation

Department of Population and Quantitative Health Sciences

Publication Date

2019-05-28

Document Type

Article

Disciplines

Cardiology | Cardiovascular Diseases | Epidemiology | Geriatrics | Health Services Administration | Health Services Research | Pharmaceutical Preparations | Therapeutics

Abstract

Deprescribing, an integral component of a continuum of good prescribing practices, is the process of medication withdrawal or dose reduction to correct or prevent medication-related complications, improve outcomes, and reduce costs. Deprescribing is particularly applicable to the commonly encountered multimorbid older adult with cardiovascular disease and concomitant geriatric conditions such as polypharmacy, frailty, and cognitive dysfunction-a combination rarely addressed in current clinical practice guidelines. Triggers to deprescribe include present or expected adverse drug reactions, unnecessary polypharmacy, and the need to align medications with goals of care when life expectancy is reduced. Using a framework to deprescribe, this review addresses the rationale, evidence, and strategies for deprescribing cardiovascular and some noncardiovascular medications.

Keywords

deprescribing, geriatrics, medications, multimorbidity, multiple chronic conditions, older adults, polypharmacy

DOI of Published Version

10.1016/j.jacc.2019.03.467

Source

J Am Coll Cardiol. 2019 May 28;73(20):2584-2595. doi: 10.1016/j.jacc.2019.03.467. Link to article on publisher's site

Journal/Book/Conference Title

Journal of the American College of Cardiology

PubMed ID

31118153

Related Resources

Link to Article in PubMed

Link to Full Text

Share

COinS